12-121001041-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022895.3(C12orf43):​c.*3112A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.365 in 1,611,356 control chromosomes in the GnomAD database, including 111,479 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8658 hom., cov: 32)
Exomes 𝑓: 0.37 ( 102821 hom. )

Consequence

C12orf43
NM_022895.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0600

Publications

70 publications found
Variant links:
Genes affected
C12orf43 (HGNC:25719): (chromosome 12 open reading frame 43) Predicted to be involved in Spemann organizer formation and negative regulation of Wnt signaling pathway. Predicted to be located in nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022]
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
HNF1A Gene-Disease associations (from GenCC):
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • type 1 diabetes mellitus 20
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hyperinsulinism due to HNF1A deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonpapillary renal cell carcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 12-121001041-T-C is Benign according to our data. Variant chr12-121001041-T-C is described in ClinVar as Benign. ClinVar VariationId is 673537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C12orf43NM_022895.3 linkc.*3112A>G 3_prime_UTR_variant Exon 6 of 6 ENST00000288757.7 NP_075046.1
HNF1ANM_000545.8 linkc.1769-24T>C intron_variant Intron 9 of 9 ENST00000257555.11 NP_000536.6 P20823E0YMI7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C12orf43ENST00000288757.7 linkc.*3112A>G 3_prime_UTR_variant Exon 6 of 6 1 NM_022895.3 ENSP00000288757.5 Q96C57
HNF1AENST00000257555.11 linkc.1769-24T>C intron_variant Intron 9 of 9 1 NM_000545.8 ENSP00000257555.5 A0A0A0MQU7

Frequencies

GnomAD3 genomes
AF:
0.318
AC:
48329
AN:
151914
Hom.:
8654
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.378
Gnomad AMR
AF:
0.393
Gnomad ASJ
AF:
0.507
Gnomad EAS
AF:
0.491
Gnomad SAS
AF:
0.515
Gnomad FIN
AF:
0.385
Gnomad MID
AF:
0.574
Gnomad NFE
AF:
0.356
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.392
AC:
96664
AN:
246892
AF XY:
0.403
show subpopulations
Gnomad AFR exome
AF:
0.137
Gnomad AMR exome
AF:
0.402
Gnomad ASJ exome
AF:
0.506
Gnomad EAS exome
AF:
0.492
Gnomad FIN exome
AF:
0.370
Gnomad NFE exome
AF:
0.366
Gnomad OTH exome
AF:
0.395
GnomAD4 exome
AF:
0.369
AC:
539129
AN:
1459324
Hom.:
102821
Cov.:
41
AF XY:
0.375
AC XY:
272574
AN XY:
725964
show subpopulations
African (AFR)
AF:
0.137
AC:
4593
AN:
33474
American (AMR)
AF:
0.405
AC:
18096
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.509
AC:
13314
AN:
26132
East Asian (EAS)
AF:
0.526
AC:
20873
AN:
39678
South Asian (SAS)
AF:
0.520
AC:
44807
AN:
86228
European-Finnish (FIN)
AF:
0.364
AC:
18750
AN:
51512
Middle Eastern (MID)
AF:
0.550
AC:
3171
AN:
5768
European-Non Finnish (NFE)
AF:
0.353
AC:
392650
AN:
1111502
Other (OTH)
AF:
0.379
AC:
22875
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
19663
39326
58988
78651
98314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12600
25200
37800
50400
63000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.318
AC:
48332
AN:
152032
Hom.:
8658
Cov.:
32
AF XY:
0.327
AC XY:
24304
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.146
AC:
6047
AN:
41506
American (AMR)
AF:
0.392
AC:
5992
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.507
AC:
1758
AN:
3470
East Asian (EAS)
AF:
0.490
AC:
2525
AN:
5150
South Asian (SAS)
AF:
0.514
AC:
2483
AN:
4828
European-Finnish (FIN)
AF:
0.385
AC:
4076
AN:
10580
Middle Eastern (MID)
AF:
0.562
AC:
163
AN:
290
European-Non Finnish (NFE)
AF:
0.356
AC:
24154
AN:
67904
Other (OTH)
AF:
0.373
AC:
789
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1610
3220
4831
6441
8051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.357
Hom.:
44569
Bravo
AF:
0.309
Asia WGS
AF:
0.482
AC:
1673
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
8.4
DANN
Benign
0.75
PhyloP100
0.060
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs735396; hg19: chr12-121438844; COSMIC: COSV56566379; COSMIC: COSV56566379; API